bibliographic resource 435665 [br/435665]
https://w3id.org/oc/corpus/br/435665

is a
title
  • Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial
publication date
  • 2014-01-01
contributor
format
identifier
part of